Increased midbrain 5-MT1A receptor number and responsiveness in cholestatic rats

被引:26
作者
Burak, KW [1 ]
Le, T [1 ]
Swain, MG [1 ]
机构
[1] Univ Calgary, Hlth Sci Ctr, Gastroenterol Res Grp, Liver Unit, Calgary, AB T2N 4N1, Canada
基金
英国医学研究理事会;
关键词
serotonin; 5-HT1A receptor; cholestasis;
D O I
10.1016/S0006-8993(00)03058-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Midbrain somatodendritic 5-HT1A autoreceptors play a central inhibitor?; role in the regulation of serotonergic neurotransmission. Given that serotonergic neurotransmission appears to be altered in experimental cholestatic liver disease we examined alterations in midbrain 5-HT1A autoreceptor binding and physiological responses in rats with experimental cholestatic liver disease in comparison to non-cholestatic controls. Using a standard receptor binding assay cholestatic rats exhibited an increase in midbrain 5-HT1A receptor number but no change in receptor affinity compared to controls. Midbrain 5-HT1A receptor mRNA expression as determined by semiquantitative RT-PCR was similar in cholestatic and non-cholestatic animals. In addition, cholestatic rats exhibited enhanced 5-HT1A autoreceptor-mediated hypothermic and hyperphagic responses compared to non-cholestatic controls after the administration of the highly specific 5-HT1A receptor agonist LY293284. These findings indicate that experimental cholestatic liver injury is associated with enhanced 5-HT1A autoreceptor-mediated physiological responsiveness in the setting of increased midbrain 5-HT1A receptor number but not affinity. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:376 / 379
页数:4
相关论文
共 20 条
[1]   HIPPOCAMPAL 8-[H-3]HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN BINDING-SITE DENSITIES, SEROTONIN RECEPTOR (5-HT(1A)) MESSENGER-RIBONUCLEIC-ACID ABUNDANCE, AND SEROTONIN LEVELS PARALLEL THE ACTIVITY OF THE HYPOTHALAMOPITUITARY ADRENAL AXIS IN RAT [J].
BURNET, PWJ ;
MEFFORD, IN ;
SMITH, CC ;
GOLD, PW ;
STERNBERG, EM .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (03) :1062-1070
[2]   Fatigue in primary biliary cirrhosis [J].
Cauch-Dudek, K ;
Abbey, S ;
Stewart, DE ;
Heathcote, EJ .
GUT, 1998, 43 (05) :705-710
[3]  
DEVRY J, 1995, PSYCHOPHARMACOLOGY, V121, P1
[4]   CHARACTERISTICS OF FEEDING INDUCED BY THE SEROTONIN AGONIST "8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO) TETRALIN (8-OH-DPAT) [J].
DOURISH, CT ;
HUTSON, PH ;
CURZON, G .
BRAIN RESEARCH BULLETIN, 1985, 15 (04) :377-384
[5]  
FOREMAN MM, 1994, J PHARMACOL EXP THER, V270, P1270
[6]   [H-3]8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN BINDING TO PRESYNAPTIC AND POSTSYNAPTIC 5-HYDROXYTRYPTAMINE SITES IN VARIOUS REGIONS OF THE RAT-BRAIN [J].
HALL, MD ;
ELMESTIKAWY, S ;
EMERIT, MB ;
PICHAT, L ;
HAMON, M ;
GOZLAN, H .
JOURNAL OF NEUROCHEMISTRY, 1985, 44 (06) :1685-1696
[7]   EFFECTS OF LOCAL APPLICATION OF 5-HT AND 8-OH-DPAT INTO THE DORSAL AND MEDIAN RAPHE NUCLEI ON CORE TEMPERATURE IN THE RAT [J].
HILLEGAART, V .
PSYCHOPHARMACOLOGY, 1991, 103 (03) :291-296
[8]   THE 5-HT1A RECEPTOR AGONIST, 8-OH-DPAT, PREFERENTIALLY ACTIVATES CELL BODY 5-HT AUTORECEPTORS IN RAT-BRAIN INVIVO [J].
HJORTH, S ;
MAGNUSSON, T .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1988, 338 (05) :463-471
[9]  
HOYER D, 1994, PHARMACOL REV, V46, P157
[10]  
Jones EA, 1997, HEPATOLOGY, V25, P492